Truncated midkine correlates with sensitivity to anticancer drugs and malignancy in human tumor cell line

✍ Scribed by Natsuyo Akuzawa; Shigenori Nobata; Takao Shinozawa

• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 213 KB
• Volume: 25
• Category: Article
• ISSN: 0263-6484
• DOI: 10.1002/cbf.1376

✦ Synopsis

Abstract

Midkine (MK) is a heparin binding growth factor having functions of neurite‐outgrowth, mitogenesis and tissue repair. This molecule is involved in tumor growth and metastasis. The MK molecule consists of five exons, but there is a truncated isoform, lacking exon 3. We established SW13 cells transfected with the human truncated MK cDNA. These cells were induced to undergo apoptosis by anticancer agents, cisplatin, etoposide (ETP), mitomycin C (MMC) and paclitaxel (PAX). Truncated midkine (tMK) suppressed cell death and helped the cells to be viable. When the cells were cultured on dishes coated with extracellular matrix molecules, spontaneous detachment occurred in the tMK expressing cells. Also tMK enhanced cell invasion. These results suggest that expression of tMK has cell‐protective functions and plays important roles in carcinogenesis and malignancy. Furthermore, it is suggested that tMK has a greater ability of malignant transformation than full‐length MK. Whether tMK is expressed or not will be useful information for improving cancer chemotherapy. Copyright © 2006 John Wiley & Sons, Ltd.